Testing a new uterine sampling tool during surgery
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests a new device that takes small samples from the uterus during surgery for suspected or confirmed upper reproductive tract cancer. It may help doctors collect better tissue samples safely while you are already having surgery for tumor removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You can understand the study and sign consent.
- You are having surgery to remove suspected or confirmed cancer in the upper genital tract.
- If you recently had a cervical abnormality treated (LEEP or cone biopsy), your follow-up Pap test was normal at least 4 months after treatment.
- You have not had a hysterectomy (removal of the uterus).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for early signs of uterine (endometrial) or ovarian cancer, especially in people with inherited risk. It may help doctors catch problems earlier, when treatment can be more effective.
This study tests genetic (DNA) information to help doctors identify ovarian or uterine (endometrial) cancer sooner. You may be asked to do this around the time of planned surgery, when tissue is removed and can be checked for genetic clues.
This study tests a new device that collects a sample from the vagina to see if it can find endometrial (uterine) or ovarian cancers. If you are seeing a gynecologist and can tolerate a speculum or tampon, you may be able to help.
This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.
This study checks whether a sample of fluid from the uterus (uterine lavage) can help detect ovarian or fallopian tube cancer. You may join if you are having certain gynecologic surgeries or, in a smaller group, you have a BRCA1/2 mutation.
This study is testing a new way to screen for cervical cancer using a sample you collect yourself. It aims to find a simpler, more accurate method that could replace more invasive tests.
Hear when a new Women With Suspected or Confirmed Gynecological Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.